Please enable JavaScript to continue using this application.

Compare $1521.HK vs $MRVI | Chartloom

Compare

$1521.HK vs $MRVI

1521.HK

Error

MRVI

Maravai LifeSciences Holdings Inc

Compare $1521.HK vs $MRVI

1521.HK

Error

MRVIMaravai LifeSciences Holdings Inc

1521.HK

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

MRVIMaravai LifeSciences Holdings Inc

Market cap

$1.92B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.68x

Rev growth (TTM)

-3.3%

YTD performance

118.8%

52W performance

123.4%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

1521.HK

MRVI

Not enough overlapping price history for this window.

Detailed metrics comparison

1521.HK

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

1521.HK

MRVI$1.92B

Enterprise Value

1521.HK

MRVI$2.03B

Price

1521.HK

MRVI$7.44

P/E Ratio

1521.HK

MRVIN/A

P/S Ratio

1521.HK

MRVI9.20x

EV/Sales

1521.HK

MRVI9.71x

EV/EBITDA

1521.HK

MRVI24.69x

P/B Ratio

1521.HK

MRVI10.03x

P/FCF Ratio

1521.HK

MRVIN/A

EV/FCF

1521.HK

MRVI-57.75x

PEG Ratio

1521.HK

MRVIN/A

Forward P/E (NTM)

1521.HK

MRVIN/A

Forward P/S (NTM)

1521.HK

MRVI8.68x

Revenue (TTM)

1521.HK

MRVI$209M

Revenue Growth (YoY)

1521.HK

MRVI-3.3%

Forward Rev Growth

1521.HK

MRVI6.5%

Gross Margin (TTM)

1521.HK

MRVI34.9%

Operating Margin (TTM)

1521.HK

MRVI0.0%

EBITDA Margin (TTM)

1521.HK

MRVI-10.4%

Net Margin (TTM)

1521.HK

MRVI-37.1%

FCF Margin (TTM)

1521.HK

MRVI-16.8%

Net Income (TTM)

1521.HK

MRVI$-77M

FCF (TTM)

1521.HK

MRVI$-35M

EPS (TTM)

1521.HK

MRVI-$0.52

ROE (TTM)

1521.HK

MRVI-3542.0%

ROA (TTM)

1521.HK

MRVI-1054.0%

ROIC (TTM)

1521.HK

MRVI-1572.0%

Cash

1521.HK

MRVI$70M

Debt

1521.HK

MRVI$177M

Net Cash/Debt

1521.HK

MRVI$-107M

Current Ratio (TTM)

1521.HK

MRVI4.05x

Quick Ratio (TTM)

1521.HK

MRVI2.63x

Debt/Equity (TTM)

1521.HK

MRVI0.86x

Debt/Assets (TTM)

1521.HK

MRVI0.0%

Interest Coverage (TTM)

1521.HK

MRVIN/A

Net Debt/EBITDA (TTM)

1521.HK

MRVI0.00x

Beta

1521.HK

MRVI0.63

52W Performance

1521.HK

MRVI123.4%

YTD Performance

1521.HK

MRVI118.8%

% from 52W High

1521.HK

MRVI-21.0%

% from 52W Low

1521.HK

MRVI192.3%

Asset Turnover (TTM)

1521.HK

MRVI0.28x

FCF Yield (TTM)

1521.HK

MRVI-1.8%

Earnings Yield (TTM)

1521.HK

MRVI-4.0%

Dividend Yield (TTM)

1521.HK

MRVIN/A

Rule of 40

1521.HK

MRVI-20.1

EV/GP/RG

1521.HK

MRVI4.63

Ticker research

View 1521.HK research View MRVI research

Metric	1521.HK	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap		$1.92B
Enterprise Value		$2.03B
Price		$7.44
P/E Ratio		N/A
P/S Ratio		9.20x
EV/Sales		9.71x
EV/EBITDA		24.69x
P/B Ratio		10.03x
P/FCF Ratio		N/A
EV/FCF		-57.75x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		8.68x
Revenue & Growth
Revenue (TTM)		$209M
Revenue Growth (YoY)		-3.3%
Forward Rev Growth		6.5%
Profitability
Gross Margin (TTM)		34.9%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-10.4%
Net Margin (TTM)		-37.1%
FCF Margin (TTM)		-16.8%
Net Income (TTM)		$-77M
FCF (TTM)		$-35M
EPS (TTM)		-$0.52
ROE (TTM)		-3542.0%
ROA (TTM)		-1054.0%
ROIC (TTM)		-1572.0%
Financial Health
Cash		$70M
Debt		$177M
Net Cash/Debt		$-107M
Current Ratio (TTM)		4.05x
Quick Ratio (TTM)		2.63x
Debt/Equity (TTM)		0.86x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.63
52W Performance		123.4%
YTD Performance		118.8%
% from 52W High		-21.0%
% from 52W Low		192.3%
Efficiency & Yields
Asset Turnover (TTM)		0.28x
FCF Yield (TTM)		-1.8%
Earnings Yield (TTM)		-4.0%
Dividend Yield (TTM)		N/A
Other
Rule of 40		-20.1
EV/GP/RG		4.63
Ticker research	View 1521.HK research	View MRVI research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

1521.HK

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

1521.HK

MRVI$1.92B

Enterprise Value

1521.HK

MRVI$2.03B

Price

1521.HK

MRVI$7.44

P/E Ratio

1521.HK

MRVIN/A

P/S Ratio

1521.HK

MRVI9.20x

EV/Sales

1521.HK

MRVI9.71x

EV/EBITDA

1521.HK

MRVI24.69x

P/B Ratio

1521.HK

MRVI10.03x

P/FCF Ratio

1521.HK

MRVIN/A

EV/FCF

1521.HK

MRVI-57.75x

PEG Ratio

1521.HK

MRVIN/A

Forward P/E (NTM)

1521.HK

MRVIN/A

Forward P/S (NTM)

1521.HK

MRVI8.68x

Revenue (TTM)

1521.HK

MRVI$209M

Revenue Growth (YoY)

1521.HK

MRVI-3.3%

Forward Rev Growth

1521.HK

MRVI6.5%

Gross Margin (TTM)

1521.HK

MRVI34.9%

Operating Margin (TTM)

1521.HK

MRVI0.0%

EBITDA Margin (TTM)

1521.HK

MRVI-10.4%

Net Margin (TTM)

1521.HK

MRVI-37.1%

FCF Margin (TTM)

1521.HK

MRVI-16.8%

Net Income (TTM)

1521.HK

MRVI$-77M

FCF (TTM)

1521.HK

MRVI$-35M

EPS (TTM)

1521.HK

MRVI-$0.52

ROE (TTM)

1521.HK

MRVI-3542.0%

ROA (TTM)

1521.HK

MRVI-1054.0%

ROIC (TTM)

1521.HK

MRVI-1572.0%

Cash

1521.HK

MRVI$70M

Debt

1521.HK

MRVI$177M

Net Cash/Debt

1521.HK

MRVI$-107M

Current Ratio (TTM)

1521.HK

MRVI4.05x

Quick Ratio (TTM)

1521.HK

MRVI2.63x

Debt/Equity (TTM)

1521.HK

MRVI0.86x

Debt/Assets (TTM)

1521.HK

MRVI0.0%

Interest Coverage (TTM)

1521.HK

MRVIN/A

Net Debt/EBITDA (TTM)

1521.HK

MRVI0.00x

Beta

1521.HK

MRVI0.63

52W Performance

1521.HK

MRVI123.4%

YTD Performance

1521.HK

MRVI118.8%

% from 52W High

1521.HK

MRVI-21.0%

% from 52W Low

1521.HK

MRVI192.3%

Asset Turnover (TTM)

1521.HK

MRVI0.28x

FCF Yield (TTM)

1521.HK

MRVI-1.8%

Earnings Yield (TTM)

1521.HK

MRVI-4.0%

Dividend Yield (TTM)

1521.HK

MRVIN/A

Rule of 40

1521.HK

MRVI-20.1

EV/GP/RG

1521.HK

MRVI4.63

Ticker research

View 1521.HK research View MRVI research

Metric	1521.HK	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap		$1.92B
Enterprise Value		$2.03B
Price		$7.44
P/E Ratio		N/A
P/S Ratio		9.20x
EV/Sales		9.71x
EV/EBITDA		24.69x
P/B Ratio		10.03x
P/FCF Ratio		N/A
EV/FCF		-57.75x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		8.68x
Revenue & Growth
Revenue (TTM)		$209M
Revenue Growth (YoY)		-3.3%
Forward Rev Growth		6.5%
Profitability
Gross Margin (TTM)		34.9%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-10.4%
Net Margin (TTM)		-37.1%
FCF Margin (TTM)		-16.8%
Net Income (TTM)		$-77M
FCF (TTM)		$-35M
EPS (TTM)		-$0.52
ROE (TTM)		-3542.0%
ROA (TTM)		-1054.0%
ROIC (TTM)		-1572.0%
Financial Health
Cash		$70M
Debt		$177M
Net Cash/Debt		$-107M
Current Ratio (TTM)		4.05x
Quick Ratio (TTM)		2.63x
Debt/Equity (TTM)		0.86x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		0.63
52W Performance		123.4%
YTD Performance		118.8%
% from 52W High		-21.0%
% from 52W Low		192.3%
Efficiency & Yields
Asset Turnover (TTM)		0.28x
FCF Yield (TTM)		-1.8%
Earnings Yield (TTM)		-4.0%
Dividend Yield (TTM)		N/A
Other
Rule of 40		-20.1
EV/GP/RG		4.63
Ticker research	View 1521.HK research	View MRVI research